173 related articles for article (PubMed ID: 15676047)
1. Increased C-reactive protein in ACE-inhibitor-induced angioedema.
Bas M; Hoffmann TK; Bier H; Kojda G
Br J Clin Pharmacol; 2005 Feb; 59(2):233-8. PubMed ID: 15676047
[TBL] [Abstract][Full Text] [Related]
2. Different patterns of angioedema in patients with and without angiotensin-converting enzyme inhibitor therapy.
Herkner H; Temmel AF; Müllner M; Havel C; Hirschl MM; Kofler J; Laggner AN
Wien Klin Wochenschr; 2001 Mar; 113(5-6):167-71. PubMed ID: 11293945
[TBL] [Abstract][Full Text] [Related]
3. Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema.
Bas M; Kirchhartz N; Hochfeld J; Tüllmann C; Kumpf S; Suvorava T; Oppermann M; Hafner D; Bier H; Hoffmann TK; Balz V; Kojda G
J Allergy Clin Immunol; 2008 Apr; 121(4):969-75.e2. PubMed ID: 18395553
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department.
Banerji A; Clark S; Blanda M; LoVecchio F; Snyder B; Camargo CA
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):327-32. PubMed ID: 18450117
[TBL] [Abstract][Full Text] [Related]
5. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
6. [ACE inhibitor-induced angioedema in the head and neck region. A matter of time?].
Bas M; Kojda G; Bier H; Hoffmann TK
HNO; 2004 Oct; 52(10):886-90. PubMed ID: 15592703
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Bas M; Greve J; Stelter K; Bier H; Stark T; Hoffmann TK; Kojda G
Ann Emerg Med; 2010 Sep; 56(3):278-82. PubMed ID: 20447725
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients.
Abbosh J; Anderson JA; Levine AB; Kupin WL
Ann Allergy Asthma Immunol; 1999 May; 82(5):473-6. PubMed ID: 10353579
[TBL] [Abstract][Full Text] [Related]
9. Brief review: angiotensin converting enzyme inhibitors and angioedema: anesthetic implications.
Sarkar P; Nicholson G; Hall G
Can J Anaesth; 2006 Oct; 53(10):994-1003. PubMed ID: 16987854
[TBL] [Abstract][Full Text] [Related]
10. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment.
Cicardi M; Zingale LC; Bergamaschini L; Agostoni A
Arch Intern Med; 2004 Apr; 164(8):910-3. PubMed ID: 15111379
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitors and the allergist.
O'Hollaren MT; Porter GA
Ann Allergy; 1990 Jun; 64(6):503-6. PubMed ID: 2189318
[TBL] [Abstract][Full Text] [Related]
12. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature.
Guo X; Dick L
J Okla State Med Assoc; 1999 Feb; 92(2):71-3. PubMed ID: 10024785
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin.
Molinaro G; Cugno M; Perez M; Lepage Y; Gervais N; Agostoni A; Adam A
J Pharmacol Exp Ther; 2002 Oct; 303(1):232-7. PubMed ID: 12235256
[TBL] [Abstract][Full Text] [Related]
14. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema.
Roberts DS; Mahoney EJ; Hutchinson CT; Aliphas A; Grundfast KM
Laryngoscope; 2008 Dec; 118(12):2115-20. PubMed ID: 19029862
[TBL] [Abstract][Full Text] [Related]
15. A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema.
Cilia La Corte AL; Carter AM; Rice GI; Duan QL; Rouleau GA; Adam A; Grant PJ; Hooper NM
Hum Mutat; 2011 Nov; 32(11):1326-31. PubMed ID: 21898657
[TBL] [Abstract][Full Text] [Related]
16. Angioedema: 6 years experience with fourteen cases.
Taki M; Watanabe H; Hasegawa T; Bamba H; Shimada T; Hisa Y
Auris Nasus Larynx; 2010 Apr; 37(2):199-204. PubMed ID: 19709832
[TBL] [Abstract][Full Text] [Related]
17. Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema.
Hassen GW; Kalantari H; Parraga M; Chirurgi R; Meletiche C; Chan C; Ciarlo J; Gazi F; Lobaito C; Tadayon S; Yemane S; Velez C
J Emerg Med; 2013 Apr; 44(4):764-72. PubMed ID: 23114109
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema.
Grant NN; Deeb ZE; Chia SH
Otolaryngol Head Neck Surg; 2007 Dec; 137(6):931-5. PubMed ID: 18036423
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.
Kyrmizakis DE; Papadakis CE; Liolios AD; Karatzanis AD; Malandrakis S; Skoulakis CE; Bizakis JG; Velegrakis GA
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1416-9. PubMed ID: 15611402
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.
Sabroe RA; Black AK
Br J Dermatol; 1997 Feb; 136(2):153-8. PubMed ID: 9068723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
